MedPath

Placebo-controlled trial to compare the inhibitory and protective efficacy of epinastine hydrochloride on nasal symptoms, using a nasal provocation test with orchard grass pollen antigen disc in orchard grass pollinosis.

Not Applicable
Conditions
Orchard grass pollinosis
Registration Number
JPRN-UMIN000002721
Lead Sponsor
ippon Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects; 1) with a history of hypersensitivity to the components of epinastine hydrochloride tablet, 2) used steroids within one month of the start day of the clinical study, 3) within one week of the start day of the clinical study, used drugs that may affect the results of the clinical study (antihistamines, antiallergic drugs, vasoconstrictors), 4) without nasal response to the provocation by a history of laser therapy and/or nasal procedure for undergoing desensitization to orchard grass pollinosis, 5) with nasal diseases that affect the assessment of the nasal provocation reaction, such as acute chronic rhinitis, nasal polyps, hypertrophic rhinitis, deviated septum or sinusitis, 6) reactive to multiple antigens including pollens (cedar, mugwort) other than orchard grass, and had worsening of nasal symptoms when the nasal provocation test was conducted during the pollen dispersal season, 7) pregnancy, potential pregnancy, and breast-feeding mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effects of epinastine hydrochloride on nasal symptoms for nasal provocation test by orchard grass pollen antigen disc
Secondary Outcome Measures
NameTimeMethod
asal finding score by rhinoscopy
© Copyright 2025. All Rights Reserved by MedPath